Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Invested Capital: 2022-2025

Historic Invested Capital for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$82.3 million.

  • Gossamer Bio's Invested Capital fell 132.75% to -$82.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.3 million, marking a year-over-year decrease of 132.75%. This contributed to the annual value of $227.0 million for FY2024, which is 12.47% down from last year.
  • Latest data reveals that Gossamer Bio reported Invested Capital of -$82.3 million as of Q3 2025, which was down 78.57% from -$46.1 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Invested Capital peaked at $301.0 million during Q3 2023, and registered a low of -$82.3 million during Q3 2025.
  • Over the past 3 years, Gossamer Bio's median Invested Capital value was $223.5 million (recorded in 2024), while the average stood at $155.2 million.
  • Its Invested Capital has fluctuated over the past 5 years, first spiked by 108.92% in 2024, then crashed by 132.75% in 2025.
  • Quarterly analysis of 4 years shows Gossamer Bio's Invested Capital stood at $207.8 million in 2022, then rose by 24.82% to $259.4 million in 2023, then decreased by 12.47% to $227.0 million in 2024, then slumped by 132.75% to -$82.3 million in 2025.
  • Its Invested Capital was -$82.3 million in Q3 2025, compared to -$46.1 million in Q2 2025 and -$6.2 million in Q1 2025.